Abstract
e19538 Background: High dose therapy-autologous stem cell transplant (HDT-ASCT) prolongs progression free survival (PFS) and overall survival (OS) in multiple myeloma (MM). The use of myelo-ablativ...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have